Grant Yonehiro
Geschäftsführer bei BOLT BIOTHERAPEUTICS, INC.
Vermögen: 6 751 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Grant Yonehiro
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.
12
| Private Company | Miscellaneous Commercial Services | 12 |
Berkeley Lights, Inc.
 Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA.
2
| Extinct | Packaged Software | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Grant Yonehiro
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Founder Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree | |
| Stanford University | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | President Director/Board Member Corporate Officer/Principal | |
| Purdue University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Maryland | College/University | Doctorate Degree Undergraduate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact | |
Alba Therapeutics Corp.
 Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Founder | |
| The Johns Hopkins University | College/University | Doctorate Degree Graduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
Heartport, Inc.
 Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Medical Specialties | Human Resources Officer Corporate Officer/Principal | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Analyst | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
VantagePoint Management, Inc.
 VantagePoint Management, Inc. Investment ManagersFinance VantagePoint Management, Inc. (VantagePoint) is a venture capital firm founded in 1996 by Alan Edward Salzman, James D. Marver. The firm is headquartered in Santa Barbara, California with additional office in Beijing, China. | Investment Managers | Private Equity Analyst Private Equity Analyst | |
| The State University of New York | College/University | Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Emory University | College/University | Corporate Officer/Principal Doctorate Degree | |
| Rochester Christian University | College/University | Director/Board Member Masters Business Admin | |
| University of Mumbai | College/University | Undergraduate Degree Undergraduate Degree | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Chairman General Counsel |
Statistik
International
| Vereinigte Staaten | 45 |
| Dänemark | 4 |
| Schweiz | 3 |
| Indien | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 16 |
| Finance | 5 |
| Government | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 362 |
| Corporate Officer/Principal | 129 |
| Independent Dir/Board Member | 97 |
| Founder | 54 |
| Chairman | 50 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Jonathan Moritz | 50 |
| James Healy | 50 |
| Kenneth Lee | 40 |
| Mahendra Shah | 35 |
| Louis Lange | 35 |
| Kathy LaPorte | 34 |
| Edgar Engleman | 29 |
| Peter Moldt | 25 |
| James Sulat | 23 |
| Wayne T. Hockmeyer | 22 |
| Barbara Hackman Franklin | 22 |
| William N. Kelley | 22 |
| Herbert Conrad | 21 |
| Brian O'Callaghan | 20 |
| Ruchita Sinha | 18 |
- Börse
- Insiders
- Grant Yonehiro
- Unternehmensverbindungen
